Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for Cisplatin-Induced Nephrotoxicity in Upper GI Cancer
NCT01829178Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of silymarin in cisplatin-induced nephrotoxicity (CIN), sponsored by Tehran University of Medical Sciences. Started Aug 2013; status: completed.
02
Drugs
silymarin
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT01829178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829178.